Diphtheria Tetanus and Acellular Pertussis Booster Vaccine (Intramuscular Route)

How is Diphtheria Tetanus and Acellular Pertussis Booster Vaccine (Intramuscular Route) dosed?

The vaccine is given intramuscularly, typically into a muscle in the upper arm or thigh. The initial dose is given 5 years or more after the last dose of a DTaP series or tetanus toxoid vaccine. The second dose may be given 8 years or more after the first dose of Tdap vaccine. Tdap vaccine is also recommended for adults who are in close contact with a baby who is less than a year old and for adults who work in the healthcare field.

What is the dosage form of Diphtheria Tetanus and Acellular Pertussis Booster Vaccine (Intramuscular Route)?

The dosage forms of this vaccine are Adacel and Boostrix.

What medications are contraindication with Diphtheria Tetanus and Acellular Pertussis Booster Vaccine (Intramuscular Route)?

Medications that may interact with this vaccine include antibiotics, corticosteroids, immunosuppressants, and other vaccines. It is important to provide a complete list of medications, including over-the-counter drugs and supplements, to your healthcare provider to ensure the best guidance on vaccine administration.

How is Diphtheria Tetanus and Acellular Pertussis Booster Vaccine (Intramuscular Route) administered?

This vaccine is administered by a healthcare professional as an intramuscular injection into a muscle. It is typically given to children 10 years of age and older, to women in their third trimester of pregnancy, and to adults who have already received this vaccine in the past. The vaccine should be given according to the patient instructions provided by the healthcare professional.

What are common precautions when taking Diphtheria Tetanus and Acellular Pertussis Booster Vaccine (Intramuscular Route)?

Some common precautions when taking this vaccine include informing your doctor about any medical conditions, allergies, or past reactions to vaccines before receiving the vaccine. If you have an immunodeficiency disorder, the vaccine's effectiveness may be reduced. Tdap vaccine is recommended for women in their third trimester of pregnancy to protect newborns against pertussis, but you should discuss the vaccine's risks and benefits with your doctor if you are breastfeeding. In some cases, the vaccine may cause side effects like redness, swelling, tenderness, pain, or a lump at the injection site, tiredness, back pain, injection site bruising, muscle or joint pain, or weakness of the muscles in the face. Ensure that a trained healthcare professional administers the vaccine, and follow their instructions carefully. If you experience any unexpected side effects or concerns after receiving the vaccine, contact your healthcare provider or the FDA.